Phase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeSélidji Todagbé Agnandji, Claire‐Anne Siegrist|New England Journal of Medicine|2015Cited by 412
Influence of <i>Mycobacterium</i> <i>bovis</i> Bacillus Calmette-Guerin on Antibody and Cytokine Responses to Human Neonatal VaccinationMartin O. C. Ota, Arnaud Marchant, Susanna E. Schlegel‐Haueter et al.|The Journal of Immunology|2002Cited by 290
CpG Oligodeoxynucleotides Can Circumvent the Th2 Polarization of Neonatal Responses to Vaccines But May Fail to Fully Redirect Th2 Responses Established by Neonatal PrimingJiří Kovařík, Claire‐Anne Siegrist|The Journal of Immunology|1999Cited by 160
Maternal Antibodies Inhibit Neonatal and Infant Responses to Vaccination by Shaping the Early-Life B Cell Repertoire within Germinal CentersMaria Vono, Claire‐Anne Siegrist|Cell Reports|2019Cited by 103